spike
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
two
major
function
interact
receptor
mediat
viru
entri
induc
protect
immun
coincid
receptorbind
domain
rbd
residu
sarcov
protein
major
antigen
site
induc
neutral
antibodi
use
rbdfc
fusion
protein
contain
rbd
human
fc
model
studi
found
singl
amino
acid
substitut
rbd
could
abolish
immunogen
rbd
induc
neutral
antibodi
immun
mice
rabbit
panel
antirbd
mab
probe
observ
substitut
abl
disrupt
major
neutral
epitop
rbd
suggest
residu
critic
antigen
structur
respons
induc
protect
immun
respons
also
demonstr
rbdfc
bear
mutat
could
bind
solubl
cellassoci
angiotensinconvert
enzym
function
receptor
sarscov
fail
block
proteinmedi
pseudoviru
entri
indic
point
mutat
also
disrupt
receptorbind
motif
rbm
rbd
taken
togeth
data
provid
direct
evid
show
singl
amino
acid
residu
key
posit
rbd
determin
major
function
sarscov
protein
impli
design
sar
vaccin
therapeut
spike
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
similar
coronavirus
larg
type
transmembran
glycoprotein
incorpor
viral
envelop
provid
virion
coronalik
appear
unlik
mani
cornavirus
protein
sarscov
may
cleav
virusproduc
cell
howev
two
domain
correspond
ntermin
subunit
ctermin
subunit
process
coronavirus
defin
sequenc
align
subunit
coronaviru
protein
form
surfac
knoblik
structur
wherea
subunit
membraneanchor
form
stemlik
structur
beneath
knob
bind
coronaviru
specif
receptor
target
cell
initi
step
infect
angiotensinconvert
enzym
function
receptor
sarscov
protein
sarscov
bind
high
affin
mediat
viral
entri
fragment
within
domain
residu
defin
minim
receptorbind
domain
rbd
fig
crystal
structur
independ
fold
rbd
bound
human
reveal
residu
constitut
receptorbind
motif
rbm
domain
sarscov
protein
contain
put
fusion
peptid
two
heptad
repeat
region
associ
form
six
helix
bundl
compris
three
helic
run
antiparallel
three
helic
second
major
function
coronaviru
protein
capac
elicit
neutral
antibodi
steril
immun
therebi
consid
critic
immunogen
vaccin
develop
similarli
shown
protein
sarscov
major
protect
antigen
among
four
structur
protein
sever
live
viru
dna
vaccin
express
protein
test
preclin
studi
coincid
rbd
sarscov
protein
major
target
neutral
antibodi
induc
patient
infect
sarscov
anim
immun
inactiv
virus
protein
previous
demonstr
rbdfc
fusion
protein
contain
rbd
link
fc
portion
human
potent
induc
neutral
antibodi
potenti
develop
subunit
vaccin
sever
conformationdepend
neutral
epitop
conf
ivi
identifi
rbd
although
rbd
major
neutral
domain
sarscov
protein
also
contain
neutral
epitop
region
interestingli
recent
report
major
function
fulllength
protein
ie
mediat
viral
entri
induc
neutral
antibodi
could
abolish
singl
amino
acid
substitut
rbd
eg
studi
use
rbdfc
model
molecul
investig
impact
substitut
immunogen
receptorbind
activ
independ
fold
rbd
data
import
understand
mechan
singl
amino
acid
residu
determin
major
function
sarscov
protein
recombin
protein
mab
plasmid
encod
receptorbind
domain
residu
sarscov
protein
access
fuse
fc
portion
human
rbdfc
previous
describ
rbdfc
bear
substitut
design
gener
mutagenesi
use
quickchang
xl
kit
stratagen
verifi
dna
sequenc
recombin
fusion
protein
express
cell
transfect
plasmid
use
fugen
reagent
boehring
mannheim
indianapoli
accord
manufactur
protocol
purifi
protein
asepharos
fast
flow
amersham
bioscienc
piscataway
nj
fulllength
protein
fl
sarscov
urbani
access
express
expressf
insect
cell
recombin
baculoviru
protein
scienc
corpor
bridgeport
ct
panel
mab
specif
rbd
sarscov
protein
prepar
laboratori
includ
mab
isol
mice
immun
rbdfc
mab
isol
mice
immun
fl
mab
isol
mice
immun
inactiv
sarscov
immun
mice
rabbit
rbdfc
mutant
respect
use
immun
mice
rabbit
four
femal
balbc
mice
week
old
per
group
subcutan
immun
lg
purifi
protein
resuspend
pb
plu
mlp
tdm
adjuv
sigma
saint
loui
mi
boost
lg
antigen
plu
mlp
tdm
adjuv
interv
four
nzw
rabbit
week
old
per
group
immun
intraderm
lg
purifi
protein
resuspend
phosphatebuff
solut
pb
ph
presenc
freund
complet
adjuv
fca
boost
three
time
freshli
prepar
emuls
lg
immunogen
freund
incomplet
adjuv
fia
interv
preimmun
sera
collect
start
immun
antisera
collect
day
boost
sera
kept
use
enzymelink
immunosorb
assay
reactiv
mous
rabbit
antisera
antirbd
mab
protein
rbdfc
fl
determin
enzymelink
immunosorb
assay
elisa
briefli
lgml
recombin
protein
use
coat
microtit
plate
corn
costar
acton
carbon
buffer
ph
overnight
block
nonfat
milk
serial
dilut
antisera
mab
ad
incub
h
follow
four
wash
pb
contain
tween
bound
antibodi
detect
hrpconjug
goat
antimous
igg
goat
antirabbit
igg
zyme
h
follow
wash
reaction
visual
addit
substrat
tetramethylbenzidin
tmb
absorb
nm
measur
elisa
plate
reader
tecan
us
research
triangl
park
nc
gener
sar
pseudoviru
neutral
assay
sarscov
pseudoviru
system
develop
laboratori
previous
describ
brief
cell
cotransfect
plasmid
encod
protein
correspond
sarscov
isol
plasmid
encod
envdefect
luciferaseexpress
genom
use
fugen
reagent
boehring
mannheim
supernat
contain
sar
pseudoviru
harvest
h
posttransfect
use
singlecycl
infect
human
cell
briefli
cell
plate
cellswel
tissuecultur
plate
grown
overnight
supernat
contain
pseudoviru
preincub
serial
dilut
mous
rabbit
antisera
h
addit
cell
cultur
refe
fresh
medium
h
later
incub
addit
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
madison
wi
aliquot
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
corn
ny
follow
addit
luciferas
substrat
promega
rel
light
unit
rlu
determin
immedi
ultra
luminomet
tecan
us
receptorbind
assay
bind
rbdfc
protein
solubl
measur
elisa
briefli
recombin
solubl
r
system
inc
minneapoli
mn
lgml
coat
onto
elisa
plate
corn
costar
carbon
buffer
ph
overnight
block
nonfat
milk
serial
dilut
rbdfc
ad
well
incub
h
wash
hrpconjug
goat
antihuman
igg
zyme
ad
incub
addit
h
wash
substrat
tmb
use
detect
bind
rbdfc
cell
measur
flow
cytometri
briefli
amino
acid
residu
arginin
essenti
immunogen
rbd
induc
neutral
antibodi
recent
report
fulllength
protein
sarscov
bear
substitut
fail
induc
neutral
antibodi
proteinpseudotyp
virus
interest
investig
whether
point
mutat
also
affect
immunogen
rbdfc
potent
induc
neutral
antibodi
mutant
gener
mutagenesi
describ
wildtyp
rbdfc
express
cell
purifi
homogen
protein
chromatographi
fig
comparison
wildtyp
mutant
protein
respect
use
immun
mice
rabbit
shown
fig
mice
rabbit
develop
robust
antibodi
respons
correspond
immunogen
third
boost
immun
rel
rbdfc
induc
higher
titer
antibodi
mice
mean
endpoint
titer
rabbit
mean
endpoint
titer
wherea
induc
antibodi
mean
endpoint
titer
mice
rabbit
use
recombin
fulllength
protein
fl
coat
antigen
measur
titer
antibodi
specif
rbd
antisera
collect
third
boost
fig
surprisingli
rbdfc
could
induc
high
titer
rbdspecif
antibodi
mice
rabbit
mean
endpoint
titer
respect
mutant
induc
rbdspecif
antibodi
titer
mice
rabbit
respect
test
whether
mous
rabbit
antisera
neutral
activ
proteinmedi
viral
entri
use
sar
pseudoviru
consist
previou
find
mous
rabbit
antibodi
induc
rbdfc
could
potent
neutral
sar
pseudoviru
mean
neutral
titer
respect
fig
howev
antibodi
induc
mutant
mice
rabbit
could
significantli
inhibit
sar
pseudoviru
higher
dilut
result
indic
substitut
sever
impair
immunogen
rbdfc
elicit
rbdspecif
neutral
antibodi
immun
anim
previous
identifi
six
group
conformationdepend
neutral
epitop
conf
ivi
panel
antirbd
mab
isol
mice
immun
rbdfc
recent
isol
set
novel
antirbd
mab
mice
immun
inactiv
sarscov
recombin
fulllength
protein
epitop
initi
group
bind
competit
design
group
ac
group
ac
respect
fig
consist
novel
antirbd
mab
possess
potent
neutral
activ
may
target
differ
epitop
shown
uniqu
specif
block
receptor
bind
data
shown
probe
antigen
structur
rbd
bear
mutat
repres
antirbd
mab
epitop
group
use
elisa
measur
reactiv
wildtyp
mutant
protein
shown
fig
antirbd
mab
strongli
react
rbdfc
three
conformationdepend
mab
abl
recogn
known
epitop
group
differ
conf
v
mab
shown
bind
competit
capac
block
receptor
bind
data
shown
interest
note
reactiv
one
mab
target
mous
antisera
linear
epitop
residu
significantli
reduc
substitut
mab
target
residu
react
protein
equal
result
suggest
substitut
disrupt
major
conformationdepend
neutral
epitop
rbd
conf
v
group
epitop
rel
stabl
conserv
character
antigen
mutant
compar
wildtyp
rbdfc
reactiv
mous
antisera
induc
fl
elisa
expect
rbdfc
react
strongli
mous
anti
sera
mean
endpoint
titer
compar
ff
protein
fig
howev
mutant
significantli
react
mous
antifl
sera
confirm
mutat
disrupt
antigen
structur
rbd
protein
sarscov
respons
bind
receptor
mediat
viral
entri
target
cell
howev
pseudoviru
express
fulllength
protein
substitut
complet
lose
infect
hypothes
substitut
might
disrupt
receptorbind
motif
rbd
therebi
pseudoviru
unabl
bind
receptor
first
use
elisabas
assay
compar
bind
activ
rbdfc
solubl
shown
fig
rbdfc
could
bind
solubl
dosedepend
manner
wherea
bind
activ
concentr
lgml
wildtyp
rbdfc
reach
reactiv
plateau
measur
whether
rbdfc
bind
cellassoci
flow
cytometri
consist
previou
report
rbdfc
bound
cell
effici
howev
could
bind
express
cell
fig
rbdfc
inhibitori
activ
pseudoviru
entri
suggest
potenti
applic
antivir
therapeut
parallel
test
inhibitori
activ
rbdfc
sar
pseudoviru
expect
rbdfc
abl
inhibit
sar
pseudoviru
infect
ic
lgml
rabbit
antisera
fig
wherea
inhibitori
effect
concentr
high
lgml
suggest
rbd
mutant
could
compet
virion
bind
receptor
taken
togeth
data
suggest
substitut
may
damag
receptorbind
motif
rbd
sarscov
emerg
winter
kill
approxim
peopl
infect
although
recent
sar
outbreak
need
develop
effect
vaccin
remain
high
import
prevent
futur
epidem
caus
sarscov
may
reemerg
anim
reservoir
end
structur
function
character
sarscov
one
highest
prioriti
yi
et
al
recent
report
singl
amino
acid
substitut
sarscov
protein
determin
viral
entri
immunogen
induc
neutral
antibodi
mechan
caus
phenotyp
remain
elucid
studi
use
rbdfc
model
studi
singl
residu
mutat
rbd
abolish
major
function
fulllength
protein
sinc
molecul
effici
bind
receptor
contain
multipl
conformationdepend
epitop
conf
ivi
capabl
induc
highli
potent
neutral
antibodi
convert
arginin
alanin
shown
disrupt
immunogen
full
length
induc
neutral
antibodi
proteinmedi
viral
entri
evalu
effect
antigen
structur
bind
function
rbd
first
found
substitut
could
complet
abolish
abil
rbd
induc
neutral
antibodi
immun
mice
rabbit
probe
antigen
epitop
rbd
bear
panel
antirbd
mab
recogn
differ
epitop
rbd
found
mutat
could
disrupt
major
neutral
epitop
result
provid
direct
evid
explain
mutant
could
induc
neutral
antibodi
although
conf
v
group
neutral
epitop
retain
partial
reactiv
correspond
mab
fail
elicit
function
antibodi
either
mice
rabbit
data
indic
residu
essenti
maintain
antigen
structur
rbd
confer
immunogen
induc
neutral
antibodi
understand
singl
residu
chang
rbd
eg
could
abolish
abil
induc
function
antibodi
disrupt
major
conformationdepend
neutral
epitop
mechan
substitut
abl
determin
immunogen
fulllength
protein
poorli
understood
although
rbd
sarscov
major
target
neutral
antibodi
protein
also
contain
neutral
epitop
domain
exampl
report
linear
epitop
region
subunit
far
away
rbd
could
induc
antibodi
moder
neutral
activ
recent
found
ntermin
region
residu
protein
also
contain
neutral
epitop
data
shown
therefor
structur
character
protein
may
provid
import
inform
understand
singl
point
mutat
rbd
affect
immunogen
entir
protein
subsequ
document
mutat
abl
complet
abolish
rbdmediat
bind
activ
receptor
molecul
could
bind
either
solubl
cellassoci
shown
elisa
flow
cytometrybas
assay
respect
moreov
rbd
substitut
also
lost
inhibitori
abil
viral
entri
therefor
data
indic
residu
essenti
antigen
structur
rbd
also
critic
receptorbind
motif
rbm
crystal
structur
rbd
complex
human
reveal
mani
contact
residu
larg
interfac
protein
receptor
determin
effici
viru
bind
infect
bound
extend
loop
protein
project
compact
core
form
residu
rbm
particular
methyl
group
threonin
residu
posit
protein
interfac
extend
hydrophob
pocket
contain
lysin
residu
posit
although
one
residu
loop
contact
residu
human
substitut
might
chang
configur
rbm
therebi
disrupt
interact
residu
rbm
subsequ
conform
chang
rbd
might
result
dramat
alter
antigen
structur
therefor
retain
critic
residu
proper
antigen
conform
rbd
import
develop
sar
vaccin
site
rbd
contain
critic
residu
eg
use
target
ration
design
therapeut
